NanoVibronix Net Worth
NanoVibronix Net Worth Breakdown | NAOV |
NanoVibronix Net Worth Analysis
NanoVibronix's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including NanoVibronix's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of NanoVibronix's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform NanoVibronix's net worth analysis. One common approach is to calculate NanoVibronix's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares NanoVibronix's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing NanoVibronix's net worth. This approach calculates the present value of NanoVibronix's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of NanoVibronix's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate NanoVibronix's net worth. This involves comparing NanoVibronix's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into NanoVibronix's net worth relative to its peers.
Enterprise Value |
|
To determine if NanoVibronix is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding NanoVibronix's net worth research are outlined below:
| NanoVibronix generated a negative expected return over the last 90 days | |
| NanoVibronix has high historical volatility and very poor performance | |
| NanoVibronix has some characteristics of a very speculative penny stock | |
| NanoVibronix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.56 M. Net Loss for the year was (3.71 M) with profit before overhead, payroll, taxes, and interest of 1.21 M. | |
| NanoVibronix currently holds about 3.94 M in cash with (2.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14. | |
| NanoVibronix has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Will NanoVibronix Inc. stock benefit from interest rate changes - Real Time Alerts Based on AI Prediction Triggered - metal.it |
NanoVibronix uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in NanoVibronix. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to NanoVibronix's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Know NanoVibronix's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as NanoVibronix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NanoVibronix backward and forwards among themselves. NanoVibronix's institutional investor refers to the entity that pools money to purchase NanoVibronix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 13.6 K | Citadel Advisors Llc | 2025-03-31 | 0.0 | Ubs Group Ag | 2025-03-31 | 5.2 K | Tower Research Capital Llc | 2025-03-31 | 1 K | Bank Of America Corp | 2025-03-31 | 7.0 | Renaissance Technologies Corp | 2024-12-31 | 0.0 | Vanguard Group Inc | 2025-03-31 | 0.0 | Geode Capital Management, Llc | 2025-03-31 | 0.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Armistice Capital, Llc | 2025-03-31 | 0.0 | Virtu Financial Llc | 2025-03-31 | 0.0 |
Follow NanoVibronix's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.18 M.Market Cap |
|
Project NanoVibronix's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.02) | (1.07) | |
| Return On Capital Employed | (3.95) | (3.75) | |
| Return On Assets | (1.02) | (1.07) | |
| Return On Equity | (5.91) | (5.61) |
When accessing NanoVibronix's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures NanoVibronix's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of NanoVibronix's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in NanoVibronix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NanoVibronix. Check NanoVibronix's Beneish M Score to see the likelihood of NanoVibronix's management manipulating its earnings.
Evaluate NanoVibronix's management efficiency
NanoVibronix has return on total asset (ROA) of (0.1208) % which means that it has lost $0.1208 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2865) %, meaning that it created substantial loss on money invested by shareholders. NanoVibronix's management efficiency ratios could be used to measure how well NanoVibronix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.07 in 2025. Return On Capital Employed is likely to climb to -3.75 in 2025. At this time, NanoVibronix's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 200.3 K in 2025, whereas Return On Tangible Assets are likely to drop (1.07) in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.23 | 0.24 | |
| Tangible Book Value Per Share | 0.23 | 0.24 | |
| Enterprise Value Over EBITDA | (4.71) | (4.95) | |
| Price Book Value Ratio | 27.93 | 29.33 | |
| Enterprise Value Multiple | (4.71) | (4.95) | |
| Price Fair Value | 27.93 | 29.33 | |
| Enterprise Value | 16.9 M | 16 M |
The management team at NanoVibronix has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Enterprise Value Revenue 2.0662 | Revenue | Quarterly Revenue Growth 0.113 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NanoVibronix insiders, such as employees or executives, is commonly permitted as long as it does not rely on NanoVibronix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NanoVibronix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
NanoVibronix time-series forecasting models is one of many NanoVibronix's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NanoVibronix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
NanoVibronix Earnings per Share Projection vs Actual
NanoVibronix Corporate Management
| CPA CPA | CFO Officer | Profile | |
| M Harrison | VP Sales | Profile | |
| Amir Rippel | Vice Marketing | Profile | |
| Stephen CPA | Chief Officer | Profile | |
| Harold MD | Chief Director | Profile | |
| Lindsey Harrison | Vice Sales | Profile |
Additional Tools for NanoVibronix Stock Analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.